← All investors
RevCycleAI · Capital Intelligence

advised by Evercore and Barclays

RCAI-tracked capital and transaction activity across revenue cycle management and healthcare administration.

1Tracked transactions
$0MAssociated disclosed value*
Sep 15, 2026Latest tracked activity

Deal timeline

Sep 15, 2026
Waystar explores strategic options including potential saleEnterprise RCM / payments · ~$5.2B market value

*Associated disclosed value is the disclosed transaction value attached to RCAI-tracked events, not necessarily equity invested by advised by Evercore and Barclays. Tracked company exposure is not a complete portfolio. RCAI analysis should be distinguished from investor-reported investment theses.